Revenue and profitability:
- Revenue: $2,014,104 in QQ3 2025, YoY growth of 609.4% and QoQ growth of 87.96%.
- Gross Profit: $514,508 with gross margin of 25.55%; YoY gross profit grew 209.7%, QoQ up 58.8%.
- Operating Income: -$1,370,970; operating margin -68.07%.
- Net Income: -$1,449,331; net margin -71.96%.
- EPS: -$0.04 (diluted -$0.04); weighted average shares 33.64 million.
Cost structure and operating leverage:
- R&D Expense: $27,947; SG&A (selling, general & administrative) $1,857,531; total operating expenses $1,885,478.
- Interest expense: -$78,499; EBITDA: -$1,370,970; EBITDA margin: -68.07%.
- Stock-based compensation: $888,494 (cash-based impact embedded in operating expenses).
Cash flow and liquidity:
- Net cash from operating activities: -$2,050,185.
- Free cash flow: -$2,050,185.
- Net change in cash: +$207,220; cash at period end: $535,966.
- Financing activities: +$2,257,405.
Balance sheet:
- Total assets: $5,711,691; total liabilities: $1,885,240; total stockholdersβ equity: $3,826,451.
- Cash and cash equivalents: $535,966; short-term debt: $1,420,116; long-term debt: $383,538; total debt: $1,803,654; net debt: $1,267,688.
- Current ratio: 3.80; quick ratio: 2.29; cash ratio: 0.36.
- Receivables: $2,356,468; inventory: $2,279,725; days sales outstanding: 105.3; days inventory outstanding: 136.8; cash conversion cycle: 241.6 days.
Valuation landscape (as of QQ3 2025):
- Price-to-Sales: 36.24x; Price-to-Book: 19.08x; Price-to-Earnings: negative (losses).
- Enterprise value to sales and other ratios show limited market valuation given the companyβs early-stage profitability profile.